Skip to main content
. 2018 Aug 17;3:32. doi: 10.1038/s41541-018-0071-7

Fig. 3.

Fig. 3

Characterization of RH5.1 clinical vaccine. a SPR analysis of the interaction of RH5.1 protein with basigin. b Anti-RH5.1 ELISA using a panel of eight PfRH5-specific mouse mAbs. Each sample was tested in triplicate. Bars show the mean plus range. c Potency ELISA using RH5.1 test sample versus RH5.1 protein standards (100, 50, and 20% concentration). Each point is the mean of triplicate readings. pAb mouse anti-PfRH5 polyclonal antibody serum control